Document is current
Any future updates will be listed below
-
Authors
Shi, Kai
Xu, Hao-jie
Lin, Zheng-lun
Chen, Tian-jie
Cai, Hong-da
-
Funding
Funding for this research was provided by:
Fujian Provincial Health Technology Project (No.2021QNA026, No.2021QNA026, No.2021QNA026, No.2021QNA026, No.2021QNA026)
Startup Fund for Scientific Research of Fujian Medical University (No.2024QH1096, No.2024QH1096, No.2024QH1096, No.2024QH1096, No.2024QH1096)
- License Information
-
More Information
Article History
Received: 14 May 2025
Accepted: 28 August 2025
First Online: 30 September 2025
Declarations
:
: The study protocol was approved by the Institutional Review Board of the First Affiliated Hospital of Fujian Medical University (Fujian, China; Approval No. MRCTA, ECFAH of FMU[2020]297) on July 23, 2020, in full compliance with the principles of the Declaration of Helsinki. In accordance with China’s Regulations on Human Genetic Resources Management and HIPAA-compliant data-handling protocols, written informed consent was formally waived by the ethics committee because of the retrospective nature of the study and the use of de-identified clinical data.
: Not applicable.
: The authors declare no competing interests.
